comparing the efficacy of two doses of vitamin A in preterm infants
Phase 3
- Conditions
- bronchopulmonary dysplasia.Bronchopulmonary dysplasia originating in the perinatal period
- Registration Number
- IRCT201505253915N17
- Lead Sponsor
- Research Vice Chancellor for Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
prematurity less than 32 weeks; birth weght less than 1500 grams
Exclusion criteria: major congenital anomalies; birth asphyxia
death before 1 week of life; cyanotic congenital heart disease; intraventricular hemorrhage grade III or more
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bronchopulmonary dysplasia. Timepoint: 28 days of life. Method of measurement: need for supplemental oxygen and FiO2.
- Secondary Outcome Measures
Name Time Method